Table 1 Baseline patient characteristics [mean ± SD, or number of patients (%)]
|  | HCM patients (n = 10) |
|---|---|
Age [years] | 57 ± 9 |
Male | 9 (90%) |
Body Surface Area [m2] | 1.99 ± 0.2 |
Body mass index [kg/m2] | 27.5 ± 4.1 |
LV morphology & risk factors | |
  Asymmetrical septal hypertrophy | 7 (70%) |
  Apical hypertrophy | 3 (30%) |
  Number of risk factors for sudden death: median (range) | 1 (0-1) |
Presence and location of late gadolinium enhancement | 9 (90%) |
  Septum | 47% |
  Anterior | 20% |
  Inferior | 20% |
  Lateral | 7% |
  Extent of late gadolinium enhancement: [% of LV mass] | 4.5% ± 5.6% |
CMR dimensions and function | |
  Indexed LV EDV [mL/m2] | 70 ± 12 |
  Indexed LV ESV [mL/m2] | 16 ± 4 |
  LV Ejection Fraction [%] | 77 ± 5 |
  LV Mass Index [g/m2] | 63 ± 12 |
  Maximum end-diastolic Wall Thickness [mm] | 22 ± 5 |